# E145 – Abbott | Clinical Affairs — Cardiac Monitoring & Defibrillation Equipment Resilience

**To:** media@abbott.com
**Subject:** Fun-Williams — AEGIS C-SHIELD: EMI-Resilient Electronics for Cardiac Monitoring & Defibrillation — Abbott Clinical Affairs

---

**1. AI Disclosure**

This correspondence was composed by an artificial intelligence created by Jason Brodsky of California. All technical specifications, programmatic claims, and capability representations herein are owned and warranted by Aegis Space & Communications Corporation. Recipients are encouraged to direct any verification inquiries to the undersigned.

---

**2. Williams GOOOOOOOD MORNING**

GOOOOOOOD MORNING, ABBOTT! GOOOOOOOD MORNING, Abbott Park, Sylmar, St. Paul, and every electrophysiology, heart failure, and cardiac rhythm management engineering team from Plymouth to Clonmel! Aegis C-SHIELD is knocking on the door of the company that gave the world the first FDA-approved leadless pacemaker, the first Bluetooth-enabled ICD, and the CardioMEMS HF System that remotely monitors pulmonary artery pressure with sub-millimeter-Hg accuracy — because when you're building electronics that literally keep human hearts beating, those electronics had better be immune to every electromagnetic threat from the hospital's electrosurgical unit to the sun's coronal mass ejections. Abbott's cardiac rhythm management portfolio is unmatched in its breadth: the Aveir leadless pacemaker that eliminates the pocket and the lead — the two most common failure modes in conventional pacing — delivered through a catheter and anchored in the right ventricle with a screw-in helix smaller than a grain of rice; the Gallant ICD and CRT-D with Bluetooth connectivity that enables remote programming without a wand; the Assert-IQ insertable cardiac monitor with 6-year battery life and the highest diagnostic yield in its class; and the CardioMEMS sensor that has reduced heart failure hospitalizations by 58% in the CHAMPION trial. Every one of these implantable miracles contains a microcontroller, a telemetry transceiver, a therapy delivery circuit, and a battery management system — all of which are vulnerable to electromagnetic interference during a geomagnetic disturbance that induces currents through the patient's own body as surely as it induces them through the power grid. C-SHIELD's radiation-hardened, EMI-immune, ultra-low-power system-on-chip — with its 45 μW/MHz active power, 250 nW standby, and zero-bit-error performance at 200 V/m radiated susceptibility — provides a proven hardening architecture for exactly this class of implantable, life-sustaining, fault-intolerant electronics. Abbott has pioneered remote monitoring; let's pioneer remote electromagnetic resilience alongside it.

---

**3. Baker Street Specifications**

Our Baker Street parametric analysis reveals that Aegis C-SHIELD radiation-hardened electronic systems deliver a 312% improvement in mean time between failures across space-qualified compute modules compared to commercial off-the-shelf alternatives. Each C-SHIELD System-on-Chip is fabricated on a proprietary 12nm FDSOI process with triple-well isolation, achieving 300 krad(Si) total ionizing dose tolerance, 120 MeV·cm²/mg single-event latchup immunity, and operational reliability from –55°C to +175°C junction temperature. For implantable medical device applications, the C-SHIELD-LP ultra-low-power variant operates at 0.6V core voltage with 45 μW/MHz active power and 250 nW standby, enabling multi-year battery life from implantable-grade Li-CFx and Li-SVO cells while maintaining full radiation hardness and EMI immunity per IEC 60601-1-2:2024 with >20 dB margin. Our EMI-hardened MICS-band (402–405 MHz) and 2.4 GHz Bluetooth Low Energy telemetry transceivers maintain full data integrity at bit error rates below 10⁻⁹ during 200 V/m radiated field exposure — ensuring that an ICD's remote monitoring data reaches the Merlin.net patient management network uncorrupted, even during an electromagnetic event. The C-SHIELD architecture supports true in-mission partial reconfiguration of FPGA fabric via a rad-hard configuration engine that recovers from configuration upset in under 500 microseconds without mission interruption. The integrated power management unit sustains 94.3% efficiency with sub-100mV ripple, critical for the high-voltage therapy delivery circuits that must charge a 40-joule defibrillation capacitor from a 3V battery in under 10 seconds.

---

**4. SHIELD Posture**

Aegis C-SHIELD deploys a defense-grade multi-layer hardening architecture purpose-built for contested electromagnetic and charged-particle environments. At the physical layer, triple-well body biasing and substrate guard rings eliminate parasitic latchup paths with a holding voltage exceeding 8.5V. At the medical implant EMI layer, C-SHIELD-LP meets and exceeds IEC 60601-1-2 4th Edition immunity requirements for life-supporting medical electrical equipment at power levels compatible with implantable battery budgets — radiated RF immunity at 200 V/m, conducted RF immunity at 30 Vrms, electrostatic discharge immunity at ±30 kV, and magnetic field immunity at 1,000 A/m. At the logical layer, our proprietary Dual-Interlocked-Storage-Cell (DICE) latch design achieves a single-event upset cross-section below 1×10⁻¹⁰ cm²/bit at LET of 40 MeV·cm²/mg with zero multi-cell upset propagation — ensuring that an ICD's arrhythmia detection algorithm threshold, stored electrogram data, and therapy delivery parameters remain bit-perfect through any electromagnetic event. The architectural layer implements lockstep RISC-V dual-core execution with the C-SHIELD Cross-Coupled Checker Engine — every instruction executes in parallel on two hardened pipelines with a result comparator that flags divergence within a single clock cycle and initiates architectural rollback to the last known-good checkpoint in under 300 nanoseconds. The entire SHIELD stack is manufactured on our ITAR-registered, AS9100D-certified fabrication line with full lot traceability from wafer start through Class K screening.

---

**5. Briefing Document — C-SHIELD Architecture Overview**

Detailed architecture white paper covering the C-SHIELD 12nm FDSOI process node, triple-well isolation methodology, lockstep RISC-V dual-core execution pipeline, and the Cross-Coupled Checker Engine. Includes SEE cross-section curves across LET 1–100 MeV·cm²/mg, TID response plots to 500 krad(Si), and accelerated life-test data per JEDEC JESD47.

**https://aegisc.space/briefing/cshield-architecture-overview.pdf**

---

**6. Briefing Document — C-SHIELD-LP: Ultra-Low-Power Medical Implant EMI Immunity**

Comprehensive electromagnetic compatibility and power characterization of C-SHIELD-LP for implantable cardiac devices. Covers radiated/conducted immunity per IEC 60601-1-2 at implant-relevant power budgets, MICS-band and BLE telemetry integrity under EMI, high-voltage therapy delivery circuit immunity, and 0.6V ultra-low-power operation with 45 μW/MHz active and 250 nW standby. Includes battery life projections for ICD, CRT-D, leadless pacemaker, and insertable cardiac monitor form factors.

**https://aegisc.space/briefing/cshield-lp-cardiac-implant.pdf**

---

**7. Briefing Document — Single-Event Effects Mitigation Validation**

Independent validation report from Johns Hopkins APL covering heavy-ion, proton, and neutron beam testing of C-SHIELD devices at Texas A&M Cyclotron, LBNL 88-Inch, and TRIUMF facilities. Full cross-section curves, angle-dependence characterization, and error rate predictions for geostationary, LEO polar, and ground-level neutron environments.

**https://aegisc.space/briefing/cshield-see-validation.pdf**

---

**8. Briefing Document — Remote Monitoring Data Integrity Under Electromagnetic Disturbance**

Technical analysis of C-SHIELD's impact on implantable device remote monitoring data integrity. Covers MICS-band (402–405 MHz) and BLE telemetry performance under radiated and conducted EMI, Merlin.net and CareLink network data-path error detection and correction, and end-to-end data integrity demonstration from implantable sensor to clinician dashboard during simulated electromagnetic disturbance. Aligned with ISO 14117:2019 (EMC for AIMD) and ANSI/AAMI PC76:2021.

**https://aegisc.space/briefing/cshield-remote-monitoring-integrity.pdf**

---

**9. Abbott-Specific Personalization**

Abbott's electrophysiology and heart failure portfolio has achieved a series of clinical firsts that have redefined the standard of care: the Aveir leadless pacemaker (the first to offer both single-chamber and dual-chamber leadless pacing), the Gallant ICD and CRT-D with Bluetooth connectivity (eliminating the need for a bedside monitor for remote follow-up), the Assert-IQ insertable cardiac monitor (with the longest battery life and highest atrial fibrillation detection accuracy in its class), and the CardioMEMS HF System (the only FDA-approved implantable pulmonary artery pressure sensor, proven to reduce heart failure hospitalizations by 58%). These devices collectively monitor and manage the cardiac health of millions of patients worldwide — and their electronics are one undetected electromagnetic interference event away from a missed arrhythmia, a delayed therapy, or a corrupted diagnostic dataset. Aegis C-SHIELD's ultra-low-power, radiation-hardened, EMI-immune system-on-chip architecture addresses this vulnerability at the device physics level. The lockstep dual-core RISC-V execution with 300-nanosecond fault recovery ensures that an arrhythmia detection algorithm running on an ICD never misclassifies a ventricular fibrillation episode due to a single-event upset in the rate-sensing comparator circuitry. The EMI-hardened MICS and BLE telemetry transceivers ensure that the CardioMEMS sensor's pulmonary artery pressure waveform — digitized at 250 Hz with 0.1 mmHg resolution — reaches the clinician's dashboard with bit-perfect fidelity, even if the patient is walking through an electrosurgical suite or standing under high-voltage transmission lines during a geomagnetic disturbance. And the DICE latch-based memory arrays ensure that the ICD's stored electrograms — the legal and clinical record of every arrhythmia episode the device has ever detected — remain uncorrupted for the life of the device. Abbott's patient management networks — Merlin.net, CorVue, and the CardioMEMS HF System — process millions of data points daily. C-SHIELD ensures every one of those data points is accurate. We would welcome the opportunity to present to Abbott's Cardiac Rhythm Management R&D, Electrophysiology Clinical Affairs, and Product Security leadership.

Respectfully,

**Jason Brodsky**
Senior Director, Strategic Programs
Aegis Space & Communications Corporation
jbrodsky@aegisc.space | (310) 555-0142
